Merck & Co will consider settling a limited number of lawsuits over its withdrawn painkiller Vioxx, a spokesman said. The drug's link to heart attacks and strokes has spawned thousands of lawsuits and last week's US$253 million jury verdict in Texas.
As recently as Wednesday, company lawyers were still saying they planned to fight each personal-injury lawsuit.
On Thursday morning, Merck said that as of Aug. 15 it faced nearly 5,000 lawsuits alleging patients were harmed by the drug -- almost 600 more cases than in its prior update five weeks earlier. The total includes about 150 potential class-action suits that could include many plaintiffs.
"Cases we'll be looking at concern ingestion of Vioxx for 18 months or more," by patients with limited heart risk factors, Kent Jarrell, spokesman for the company's legal team, told reporters.
While Merck could decide to fight some cases aggressively, Jarrell said "we could decide to settle" others.
"We are not entertaining the notion of a global settlement," he said.
Shares of Merck fell US$0.11 to close at US$27.66 in trading on the New York Stock Exchange. That is up from its November low of US$25.60 but 41 percent below its 52-week high of US$47 before its Vioxx recall last September.
Whitehouse Station-based Merck pulled the popular arthritis treatment from the market when its own study showed Vioxx doubled the risk of heart attack or stroke when taken for at least 18 months.
Jarrell said the company does not know how many patients took Vioxx for at least 18 months and also had low risks of cardiac problems but expects it to be "a relatively small number." The combination of those circumstances would strengthen the patients' cases.
"Merck is stepping up now and saying, `Maybe we should compensate people who were harmed after 18 months'" of Vioxx use, said Chris Seeger, the attorney going up against Merck in the next Vioxx trial in a state court, set to start Sept. 12 in Atlantic City.
Seeger said he thinks the shift is due to board members and shareholders angry that Merck lawyers until now insisted they would fight every lawsuit while Merck's stock price continued to suffer.
Jarrell called the comment "one lawyer's interpretation of what's going on," but would not discuss whether it is accurate.
He also would not say whether Merck has discussed possible settlements with plaintiffs' lawyers.
However, Mark Lanier, the lawyer who last week won the Texas case, said on Friday during a CNBC interview that he has received e-mails about Merck on the issue "from lawyers associated with lawyers associated with Merck."
Lanier said he expects at least 50,000 US Vioxx plaintiffs and that there are thousands more "foreign plaintiffs trying to figure out how to get into the American courts."
US Food and Drug Administration drug safety expert David Graham told the Senate Finance Committee last November that research indicates Vioxx caused up to 160,000 heart attacks and strokes.
Pharmaceuticals analyst Al Rauch at AG Edwards & Sons Inc said the shift in Merck's position on settlements appears to be a goodwill gesture after the jury in Angleton, Texas, last Friday awarded US$253.4 million in damages -- likely to be reduced to US$26 million under Texas caps on punitive damages -- to the widow of Bob Ernst. Ernst died in 2001 after taking Vioxx for eight months.
Rauch said Merck could be trying to limit unfavorable publicity by avoiding trials where patients have the strongest cases, and also may hope to show most Vioxx users who had heart attacks or strokes had risk factors such as obesity, tobacco use, high blood pressure or cholesterol, or family history of heart disease. That's likely, he said, given that most Vioxx users were older people likely to have such conditions.
"If they [Merck] can come and get no one to settle with because everyone's got a risk factor, then they can say, by itself, Vioxx does not cause heart attacks," Rauch said.
Taiwan Transport and Storage Corp (TTS, 台灣通運倉儲) yesterday unveiled its first electric tractor unit — manufactured by Volvo Trucks — in a ceremony in Taipei, and said the unit would soon be used to transport cement produced by Taiwan Cement Corp (TCC, 台灣水泥). Both TTS and TCC belong to TCC International Holdings Ltd (台泥國際集團). With the electric tractor unit, the Taipei-based cement firm would become the first in Taiwan to use electric vehicles to transport construction materials. TTS chairman Koo Kung-yi (辜公怡), Volvo Trucks vice president of sales and marketing Johan Selven, TCC president Roman Cheng (程耀輝) and Taikoo Motors Group
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
RECORD-BREAKING: TSMC’s net profit last quarter beat market expectations by expanding 8.9% and it was the best first-quarter profit in the chipmaker’s history Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), which counts Nvidia Corp as a key customer, yesterday said that artificial intelligence (AI) server chip revenue is set to more than double this year from last year amid rising demand. The chipmaker expects the growth momentum to continue in the next five years with an annual compound growth rate of 50 percent, TSMC chief executive officer C.C. Wei (魏哲家) told investors yesterday. By 2028, AI chips’ contribution to revenue would climb to about 20 percent from a percentage in the low teens, Wei said. “Almost all the AI innovators are working with TSMC to address the
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”